Intact Investment Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Intact Investment Management Inc.
- $3.01 Billion
- Q3 2025
A detailed history of Intact Investment Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Intact Investment Management Inc. holds 2,770 shares of REGN stock, worth $1.74 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,770
Previous 2,280
21.49%
Holding current value
$1.74 Million
Previous $1.2 Million
30.08%
% of portfolio
0.05%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,443Shares Held
89MCall Options Held
1.77MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.92 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.3 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.55 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.03 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.4 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $67.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...